Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
In the last 90 days, Processa Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Processa Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 9 | 8 | −1 |
| Shares | 45.0K | 48.6K | +3.52K (+7.8%) |
| Value | $101.0K | $66.5K | −$34.5K (−34.1%) |
New holders (1)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 521 | $714 | 0.00% |
Sold out (2)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Main Street Group, LTD | 100 | $209 |
| Royal Bank of Canada | 4 | $0 |